Concert Bio helps businesses manage their microbiome. We combine monitoring with analytics to develop interventions that improve the microbiome that matters to you.
Concert Bio has raised €1.7M across 1 funding round from 6 investors, most recently a Pre-Seed round in Aug 2022. Based in London, UK; active in Agritech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-08-01 | Pre-Seed |
| €1.7M |
| Day One Ventures,Nucleus Capital,Ponderosa Ventures,Potential Ventures,Tet Ventures,The Venture Collective |
| View deal → |
